FitLife Brands, Inc. (FTLF) 10-Year Financial Performance & Capital Metrics

FTLF • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessDietary Supplements & Vitamins

AboutFitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.Show more

Revenue $64M +22.3%
EBITDA $13M +73.0%
Net Income $9M +69.6%
EPS (Diluted) 0.91 +68.1%
Gross Margin 43.56% +7.1%
EBITDA Margin 20.52% +41.4%
Operating Margin 20.35% +42.0%
Net Margin 13.94% +38.7%
ROE 28.45% +30.1%
ROIC 21.59% +3.4%
Debt/Equity 0.37 -50.0%
Interest Coverage 9.60 +30.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 24.4%
✓Strong 5Y profit CAGR of 27.2%
✓Strong Piotroski F-Score: 8/9
✓Strong 5Y sales CAGR of 27.0%
✓Healthy 5Y average net margin of 19.7%
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y12.44%

5Y27.02%

3Y32.18%

TTM12.44%

Profit (Net Income) CAGR

10Y18.3%

5Y27.2%

3Y18.42%

TTM-19.51%

EPS CAGR

10Y13.76%

5Y25.5%

3Y18.18%

TTM-17.94%

ROCE

10Y Avg14.62%

5Y Avg35.27%

3Y Avg26.83%

Latest28.45%

Peer Comparison

Dietary Supplements & Vitamins

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SMPLThe Simply Good Foods Company	1.96B	21.15	20.74	8.98%	6.26%	5.23%	8.07%	0.17
FTLFFitLife Brands, Inc.	146.88M	15.64	17.23	22.33%	9.57%	16.13%	6.54%	0.37
USNAUSANA Health Sciences, Inc.	394.87M	21.60	9.86	-7.22%	1.86%	2.93%	12.9%	0.07
LFVNLifeVantage Corporation	80.4M	6.33	8.33	14.17%	4.78%	34.53%	13.07%	0.34
HLFHerbalife Nutrition Ltd.	1.72B	16.68	6.67	-1.37%	6.47%		9.48%
ATPCAgape ATP Corporation	5.45M	0.11	-0.17	-7.57%	-183%	-11.92%		0.19
HCWCHealthy Choice Wellness Corp.	5.38M	0.30	-0.62	24.57%	-5.44%	-73.95%		10.72

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	17.93M	25.31M	17.8M	17.08M	19.5M	22.11M	27.91M	28.8M	52.7M	64.47M
Revenue Growth %	-0.1%	0.41%	-0.3%	-0.04%	0.14%	0.13%	0.26%	0.03%	0.83%	0.22%
Cost of Goods Sold+	11.65M	15.24M	12.71M	10.33M	11.44M	12.57M	15.41M	16.77M	31.27M	36.39M
COGS % of Revenue	0.65%	0.6%	0.71%	0.61%	0.59%	0.57%	0.55%	0.58%	0.59%	0.56%
Gross Profit+	6.28M	10.07M	5.09M	6.75M	8.06M	9.54M	12.5M	12.03M	21.43M	28.08M
Gross Margin %	0.35%	0.4%	0.29%	0.39%	0.41%	0.43%	0.45%	0.42%	0.41%	0.44%
Gross Profit Growth %	-0.11%	0.6%	-0.49%	0.32%	0.2%	0.18%	0.31%	-0.04%	0.78%	0.31%
Operating Expenses+	7.37M	9.6M	8.11M	6.09M	5.48M	5.19M	6.27M	6.33M	13.88M	14.96M
OpEx % of Revenue	0.41%	0.38%	0.46%	0.36%	0.28%	0.23%	0.22%	0.22%	0.26%	0.23%
Selling, General & Admin	7.07M	9.12M	7.71M	6.02M	5.43M	5.15M	6.21M	6.27M	12.16M	9.97M
SG&A % of Revenue	0.39%	0.36%	0.43%	0.35%	0.28%	0.23%	0.22%	0.22%	0.23%	0.15%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-13.77K	5.2K	-8.07K	69K	52K	38K	59K	66K	1.72M	4.99M
Operating Income+	-1.09M	472.26K	-8.95M	653K	2.58M	4.35M	6.23M	5.7M	7.55M	13.12M
Operating Margin %	-0.06%	0.02%	-0.5%	0.04%	0.13%	0.2%	0.22%	0.2%	0.14%	0.2%
Operating Income Growth %	-1.59%	1.43%	-19.96%	1.07%	2.95%	0.68%	0.43%	-0.08%	0.32%	0.74%
EBITDA+	-789.59K	950.5K	-8.54M	722K	2.63M	4.38M	6.29M	5.77M	7.64M	13.23M
EBITDA Margin %	-0.04%	0.04%	-0.48%	0.04%	0.14%	0.2%	0.23%	0.2%	0.15%	0.21%
EBITDA Growth %	-1.38%	2.2%	-9.99%	1.08%	2.65%	0.67%	0.43%	-0.08%	0.33%	0.73%
D&A (Non-Cash Add-back)	300.14K	478.24K	409K	69K	52K	38K	59K	66K	94K	108K
EBIT	-1.1M	477.47K	-8.96M	653K	2.66M	4.35M	6.23M	5.82M	8.03M	13.24M
Net Interest Income+	-90.41K	-109.39K	-112K	-133K	-47K	-6K	25K	121K	-736K	-1.3M
Interest Income	0	0	0	0	0	9K	25K	121K	289K	69K
Interest Expense	90.41K	109.39K	112.13K	133K	47K	15K	0	0	1.02M	1.37M
Other Income/Expense	-104.18K	-104.19K	-120K	-133K	36K	64K	478K	121K	-547K	-1.25M
Pretax Income+	-1.19M	368.08K	-9.07M	520K	2.62M	4.41M	6.71M	5.82M	7M	11.87M
Pretax Margin %	-0.07%	0.01%	-0.51%	0.03%	0.13%	0.2%	0.24%	0.2%	0.13%	0.18%
Income Tax+	-27.97K	0	689K	11K	7K	-4.42M	1.3M	1.39M	1.71M	2.89M
Effective Tax Rate %	0.98%	1%	1.08%	0.98%	1.03%	2%	0.81%	0.76%	0.76%	0.76%
Net Income+	-1.17M	368.08K	-9.76M	509K	2.7M	8.82M	5.41M	4.43M	5.3M	8.98M
Net Margin %	-0.07%	0.01%	-0.55%	0.03%	0.14%	0.4%	0.19%	0.15%	0.1%	0.14%
Net Income Growth %	-1.7%	1.32%	-27.52%	1.05%	4.3%	2.27%	-0.39%	-0.18%	0.2%	0.7%
Net Income (Continuing)	-1.17M	368.08K	-9.76M	509K	2.61M	8.82M	5.41M	4.43M	5.3M	8.98M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.16	0.05	-1.16	0.46	0.29	0.97	0.55	0.45	0.54	0.91
EPS Growth %	-1.65%	1.31%	-24.2%	1.4%	-0.37%	2.34%	-0.43%	-0.19%	0.21%	0.68%
EPS (Basic)	0.00	0.05	-1.16	0.46	0.31	1.05	0.61	0.49	0.59	0.98
Diluted Shares Outstanding	6.94M	8.27M	8.41M	875.49K	8.74M	9.1M	9.76M	9.95M	9.81M	9.9M
Basic Shares Outstanding	6.94M	8.27M	8.41M	875.49K	8.21M	8.47M	8.81M	9.11M	8.98M	9.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	9.54M	8.13M	6.32M	5.44M	5.7M	11.75M	17.68M	23.2M	14.69M	18.14M
Cash & Short-Term Investments	1.53M	1.29M	1.26M	259K	265K	6.34M	9.9M	13.28M	1.14M	4.47M
Cash Only	1.53M	1.29M	1.26M	259K	265K	6.34M	9.9M	13.28M	1.14M	4.47M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.7M	2.63M	1.96M	1.88M	2.37M	1.8M	945K	705K	3.06M	1.65M
Days Sales Outstanding	54.98	37.9	40.25	40.16	44.29	29.66	12.36	8.93	21.23	9.35
Inventory	4.79M	3.76M	2.87M	3.52M	3M	3.53M	6.52M	9.11M	9.09M	11.07M
Days Inventory Outstanding	150.04	89.96	82.54	124.46	95.69	102.44	154.44	198.18	106.12	111.08
Other Current Assets	360.56K	122.78K	5K	223K	0	40K	0	116K	1.4M	950K
Total Non-Current Assets+	8.02M	7.42M	542.1K	424K	625K	4.87M	3.82M	2.5M	40.65M	40.39M
Property, Plant & Equipment	226.8K	171K	295.19K	189K	390K	306K	228K	149K	258K	487K
Fixed Asset Turnover	79.06x	148.03x	60.30x	90.35x	49.99x	72.26x	122.43x	193.31x	204.26x	132.38x
Goodwill	0	0	0	225K	225K	225K	358K	358K	13.29M	13.02M
Intangible Assets	6.93M	6.51M	225K	0	0	0	192K	150K	26.31M	26.23M
Long-Term Investments	52.7K	52.7K	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	21.91K	10K	10K	4.34M	3.04M	0	0	0
Total Assets+	17.56M	15.55M	6.86M	5.86M	6.33M	16.62M	21.51M	25.71M	55.35M	58.53M
Asset Turnover	1.02x	1.63x	2.59x	2.91x	3.08x	1.33x	1.30x	1.12x	0.95x	1.10x
Asset Growth %	0.74%	-0.11%	-0.56%	-0.15%	0.08%	1.63%	0.29%	0.2%	1.15%	0.06%
Total Current Liabilities+	6.53M	4.64M	5.95M	3.55M	2.78M	4.14M	4.06M	4.27M	10.34M	11.31M
Accounts Payable	3.36M	1.6M	2.97M	2.63M	2.01M	3.25M	2.88M	3M	3.26M	4.07M
Days Payables Outstanding	105.37	38.24	85.42	92.84	64.15	94.23	68.22	65.19	38.07	40.79
Short-Term Debt	2.07M	2.51M	2.37M	500K	0	0	0	0	4.5M	4.5M
Deferred Revenue (Current)	1000K	0	0	0	0	0	0	0	0	0
Other Current Liabilities	95.78K	0	0	446K	256K	345K	632K	590K	571K	564K
Current Ratio	1.46x	1.75x	1.06x	1.53x	2.05x	2.84x	4.36x	5.43x	1.42x	1.60x
Quick Ratio	0.73x	0.94x	0.58x	0.54x	0.97x	1.99x	2.75x	3.30x	0.54x	0.62x
Cash Conversion Cycle	99.66	89.62	37.38	71.78	75.83	37.88	98.58	141.93	89.28	79.63
Total Non-Current Liabilities+	914.14K	369.18K	0	0	208K	611K	103K	49K	17.97M	11.09M
Long-Term Debt	914.14K	369.18K	0	0	0	453K	0	0	15.51M	8.55M
Capital Lease Obligations	0	0	0	0	208K	158K	103K	49K	51K	331K
Deferred Tax Liabilities	0	95K	0	0	0	0	0	0	2.41M	2.21M
Other Non-Current Liabilities	0	0	0	0	0	-1	0	0	0	0
Total Liabilities	7.45M	5.01M	5.95M	3.55M	2.98M	4.75M	4.16M	4.32M	28.31M	22.41M
Total Debt+	2.98M	2.88M	2.36M	500K	254K	661K	158K	103K	20.15M	13.46M
Net Debt	1.45M	1.58M	1.1M	241K	-11K	-5.67M	-9.74M	-13.17M	19.01M	8.99M
Debt / Equity	0.30x	0.27x	2.59x	0.22x	0.08x	0.06x	0.01x	0.00x	0.75x	0.37x
Debt / EBITDA	-	3.03x	-	0.69x	0.10x	0.15x	0.03x	0.02x	2.64x	1.02x
Net Debt / EBITDA	-	1.67x	-	0.33x	-0.00x	-1.29x	-1.55x	-2.28x	2.49x	0.68x
Interest Coverage	-12.05x	4.32x	-79.84x	4.91x	54.91x	289.73x	-	-	7.37x	9.60x
Total Equity+	10.11M	10.53M	911.6K	2.31M	3.34M	11.87M	17.35M	21.39M	27.04M	36.13M
Equity Growth %	0.51%	0.04%	-0.91%	1.54%	0.44%	2.55%	0.46%	0.23%	0.26%	0.34%
Book Value per Share	1.46	1.27	0.11	2.64	0.38	1.31	1.78	2.15	2.76	3.65
Total Shareholders' Equity	10.11M	10.53M	911.6K	2.31M	3.34M	11.87M	17.35M	21.39M	27.04M	36.13M
Common Stock	104.44K	104.5K	106.82K	111K	12K	42K	46K	45K	92K	92K
Retained Earnings	-20.81M	-20.45M	-30.21M	-29.8M	-27.11M	-18.55M	-13.14M	-8.71M	-3.42M	5.57M
Treasury Stock	-142.23K	-44.41K	0	0	-1.62M	-1.79M	-2.09M	0	0	0
Accumulated OCI	-581.52K	-621.93K	-676.63K	-713K	0	0	0	0	-292K	-662K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-2.46M	-88.42K	665.78K	258K	2.26M	5.72M	4.48M	4.13M	4.22M	9.61M
Operating CF Margin %	-0.14%	-0%	0.04%	0.02%	0.12%	0.26%	0.16%	0.14%	0.08%	0.15%
Operating CF Growth %	-2.63%	0.96%	8.53%	-0.61%	7.76%	1.53%	-0.22%	-0.08%	0.02%	1.28%
Net Income	-1.17M	368.08K	-9.76M	509K	2.61M	8.82M	5.41M	4.43M	5.3M	8.98M
Depreciation & Amortization	300.14K	478.24K	409.48K	69K	52K	38K	59K	66K	94K	108K
Stock-Based Compensation	453.78K	98.69K	140K	293K	0	78K	452K	363K	473K	459K
Deferred Taxes	-66.56M	0	689K	0	0	0	0	0	0	0
Other Non-Cash Items	-350.51K	98.69K	7.12M	-424K	220K	-49K	-399K	45K	360K	3K
Working Capital Changes	-1.24M	-1.03M	2.89M	104K	-621K	-3.17M	-1.04M	-773K	-2M	56K
Change in Receivables	-116.27K	-108.08K	-429.15K	1.33M	-89K	-144K	1.01M	247K	-882K	361K
Change in Inventory	-1.56M	1.03M	972.94K	-707K	249K	-97K	-2.94M	-2.64M	1.03M	-2.11M
Change in Payables	522.59K	-1.77M	1.38M	-346K	-610K	1.23M	-366K	115K	-2.68M	866K
Cash from Investing+	-411.04K	-71K	-185.06K	4K	0	0	-529K	0	-35.99M	-10K
Capital Expenditures	-12.83K	-23.41K	-185.06K	0	0	0	0	0	-106K	-10K
CapEx % of Revenue	0%	0%	0.01%	-	-	-	-	-	0%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-398.21K	-47.59K	0	4K	0	0	0	0	-18.79M	0
Cash from Financing+	-660.2K	-80.1K	-511.82K	-1.26M	-2.25M	350K	-390K	-750K	20.3M	-6.98M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	-63K	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	600K	0	71K	54K	29K	171K	17K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.47M	-111.82K	480.72K	258K	2.26M	5.72M	4.48M	4.13M	4.11M	9.6M
FCF Margin %	-0.14%	-0%	0.03%	0.02%	0.12%	0.26%	0.16%	0.14%	0.08%	0.15%
FCF Growth %	-2.64%	0.95%	5.3%	-0.46%	7.76%	1.53%	-0.22%	-0.08%	-0%	1.33%
FCF per Share	-0.36	-0.01	0.06	0.29	0.26	0.63	0.46	0.42	0.42	0.97
FCF Conversion (FCF/Net Income)	2.11x	-0.24x	-0.07x	0.51x	0.84x	0.65x	0.83x	0.93x	0.80x	1.07x
Interest Paid	0	0	0	0	47K	12K	0	0	777K	1.36M
Taxes Paid	0	0	0	0	0	0	0	3K	698K	2.5M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-13.86%	3.57%	-170.59%	31.56%	95.4%	116%	37.03%	22.87%	21.87%	28.45%
Return on Invested Capital (ROIC)	-10.02%	2.99%	-95.03%	21.44%	65.77%	68.41%	67.69%	54.05%	20.87%	21.59%
Gross Margin	35.01%	39.79%	28.6%	39.5%	41.34%	43.13%	44.8%	41.78%	40.67%	43.56%
Net Margin	-6.5%	1.45%	-54.84%	2.98%	13.84%	39.91%	19.38%	15.38%	10.05%	13.94%
Debt / Equity	0.30x	0.27x	2.59x	0.22x	0.08x	0.06x	0.01x	0.00x	0.75x	0.37x
Interest Coverage	-12.05x	4.32x	-79.84x	4.91x	54.91x	289.73x	-	-	7.37x	9.60x
FCF Conversion	2.11x	-0.24x	-0.07x	0.51x	0.84x	0.65x	0.83x	0.93x	0.80x	1.07x
Revenue Growth	-10.16%	41.17%	-29.68%	-4.06%	14.17%	13.41%	26.24%	3.19%	82.97%	22.33%

Revenue by Geography

	2024
UNITED STATES	61.47M
UNITED STATES Growth	-
Non-US	3M
Non-US Growth	-

Frequently Asked Questions

Valuation & Price

FitLife Brands, Inc. (FTLF) has a price-to-earnings (P/E) ratio of 17.2x. This is roughly in line with market averages.

Growth & Financials

FitLife Brands, Inc. (FTLF) reported $70.6M in revenue for fiscal year 2024. This represents a 484% increase from $12.1M in 2011.

FitLife Brands, Inc. (FTLF) grew revenue by 22.3% over the past year. This is strong growth.

Yes, FitLife Brands, Inc. (FTLF) is profitable, generating $6.8M in net income for fiscal year 2024 (13.9% net margin).

Dividend & Returns

FitLife Brands, Inc. (FTLF) has a return on equity (ROE) of 28.4%. This is excellent, indicating efficient use of shareholder capital.

FitLife Brands, Inc. (FTLF) generated $8.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...